Cargando…
Developing therapeutic approaches for metachromatic leukodystrophy
Metachromatic leukodystrophy (MLD) is an autosomal recessive lysosomal disorder caused by the deficiency of arylsulfatase A (ASA), resulting in impaired degradation of sulfatide, an essential sphingolipid of myelin. The clinical manifestations of MLD are characterized by progressive demyelination an...
Autores principales: | Patil, Shilpa A, Maegawa, Gustavo HB |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3743609/ https://www.ncbi.nlm.nih.gov/pubmed/23966770 http://dx.doi.org/10.2147/DDDT.S15467 |
Ejemplares similares
-
Intrathecal baclofen in metachromatic leukodystrophy
por: van der Veldt, Nikki, et al.
Publicado: (2018) -
Metachromatic Leukodystrophy: Diagnosis, Modeling, and Treatment Approaches
por: Shaimardanova, Alisa A., et al.
Publicado: (2020) -
Diffusion tensor imaging in metachromatic leukodystrophy
por: van Rappard, Diane F., et al.
Publicado: (2018) -
Metachromatic leukodystrophy and transplantation: remyelination, no cross‐correction
por: Wolf, Nicole I., et al.
Publicado: (2020) -
Acetobacter indonesiensis Bacteremia in Child with Metachromatic Leukodystrophy
por: Kohlmann, Rebekka, et al.
Publicado: (2016)